WallStSmart
RPID

Rapid Micro Biosystems Inc

NASDAQ: RPID · HEALTHCARE · MEDICAL DEVICES

$2.30
-6.50% today

Updated 2026-04-29

Market cap
$112.59M
P/E ratio
P/S ratio
3.35x
EPS (TTM)
$-1.00
Dividend yield
52W range
$2 – $5
Volume
0.2M

Rapid Micro Biosystems Inc (RPID) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201020112019202020212022202320242025
Revenue$16.08M$10.97M$16.51M$16.08M$23.23M$17.13M$22.52M$28.05M$33.59M
Revenue growth (YoY)-31.8%+50.6%-2.6%+44.5%-26.3%+31.4%+24.6%+19.7%
Cost of revenue$16.02M$11.78M$16.75M$24.15M$30.97M$25.67M$28.00M$28.16M$25.98M
Gross profit$59000.00$-234000.00$-8.07M$-7.74M$-8.54M$-5.49M$-109000.00$7.61M
Gross margin0.4%0.0%-1.4%-50.2%-33.3%-49.8%-24.4%-0.4%22.7%
R&D$5.43M$6.53M$9.78M$12.87M$12.82M$14.60M$13.60M
SG&A$1.76M$2.52M$8.92M$9.98M$17.89M$26.82M$24.94M$21.95M$22.75M
Operating income$-18.63M$-30.54M$-47.23M$-63.22M$-56.56M$-49.92M$-47.39M
Operating margin0.0%0.0%-112.9%-190.0%-203.3%-369.0%-251.2%-178.0%-141.1%
EBITDA$-16.87M$-32.00M$-45.70M$-60.38M$-53.46M$-46.56M$-44.14M
EBITDA margin0.0%0.0%-102.2%-199.0%-196.7%-352.4%-237.4%-166.0%-131.4%
EBIT$-18.37M$-33.50M$-47.23M$-63.22M$-56.56M$-49.92M$-47.39M
Interest expense$0.00$0.00$2.38M$3.45M$2.65M$1.78M$1.09M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-21.17M$-37.08M$-73.52M$-60.81M$-52.47M$-46.89M$-47.12M
Net income growth (YoY)-75.1%-98.3%+17.3%+13.7%+10.6%-0.5%
Profit margin0.0%0.0%-128.2%-230.6%-316.5%-354.9%-233.0%-167.2%-140.3%